Pfizer (NYSE:PFE) has opened bullishly above the pivot of $25.32 today and has reached the first level of resistance at $25.50. Investors may be interested in a cross of the next upside pivot targets of $25.64 and $25.96.
Pfizer (NYSE:PFE) has potential upside of 9.7% based on a current price of $25.47 and analysts' consensus price target of $27.95. The stock should find initial support at its 50-day moving average (MA) of $24.97 and further support at its 200-day MA of $23.44.
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
Over the past year, Pfizer has traded in a range of $20.75 to $26.09 and is now at $25.47, 23% above that low. The 200-day and 50-day moving averages have moved 0.46% higher and 0.18% higher over the past week, respectively.